MedPath

Effects of infant formula enriched with butyrate on immune and intestinal functions

Not Applicable
Completed
Conditions
prevention of immunological impairment in healty newborns
Diet and Nutrition - Other diet and nutrition disorders
Inflammatory and Immune System - Normal development and function of the immune system
Registration Number
ACTRN12614000533695
Lead Sponsor
Federico II University of Naples
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Caucasian newborns exclusively fed artificially for maternal choice, gestational age greater than 37 weeks . Obtaining informed consent.

Exclusion Criteria

Maternal factors: a history of autoimmune diseases, cancers, infectious or inflammatory diseases that required antibiotic therapy in pregnancy, diabetes, preeclampsia, lipid disorders, vaginal swab positive for Group B streptococcus, prolonged rupture of membranes.
Neonatal Factors: twins, a history of severe asphyxia, meconium aspiration syndrome, immunodeficiencies, congenital infections, genetic disorders and chromosomal abnormalities, malformations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of innate immunity by measurement of beta-defensins, cathelecidin LL-37 in faecal and blood samples and development of adaptive immunity through the measurement of sIgA in faecal and blood samples[at the third and fifth day of life and at the twenty-eighth day of life];Development of functional maturation of intestine through the monitoring of the citrulline levels in blood samples.[at twenty-eight days of life]
Secondary Outcome Measures
NameTimeMethod
assessment of clinical improvement through evacuative patter, episodes of colic and crying, regurgitation, vomiting. These outcomes is assessed by daily diary completed by infant's mother.[at the third and fifth day of life and at the twenty-eighth day of life]
© Copyright 2025. All Rights Reserved by MedPath